The JAMA Network Open study found that people diagnosed with attention-deficit/hyperactivity disorder face a 89% to 90% higher rate of death by suicide compared to individuals without ADHD.

Overview Debates Related claims Topics Sources

Sixteen-year-old Elise Sebastian killed herself in 2021 at Essex Partnership University NHS Foundation Trust after hospital staff muted the Oxevision camera monitoring alarm system.

The proposed FY26 budget restructuring includes a $1 billion funding reduction affecting community mental health centers, suicide prevention, and substance use treatment programs.

The JAMA Network Open systematic review and meta-analysis evaluated 19 observational studies encompassing nearly 16 million study participants across three continents, with 63.9% of participants being male.

The meta-analysis revealed a 27% increase in natural-cause mortality risk among individuals diagnosed with attention-deficit/hyperactivity disorder compared to those without the condition.

A JAMA Network Open systematic review and meta-analysis led by University College London researchers found that attention-deficit/hyperactivity disorder is associated with a 70% to 71% higher rate of all-cause mortality.

Natural-cause mortality in ADHD patients is linked to higher rates of cardiovascular disease, diabetes, metabolic disorders, health risk behaviors like smoking and alcohol use, and healthcare access barriers.

The JAMA Network Open meta-analysis showed that individuals with attention-deficit/hyperactivity disorder experience a 55% higher rate of death from intentional or accidental injuries than those without ADHD.

Researchers observed that co-existing mental health conditions like depression, along with emotional regulation and impulse control challenges, may contribute to elevated suicide rates among people with ADHD.

Researchers warned that the apparent 25% mortality reduction associated with ADHD medication is based on only three observational studies, preventing causal conclusions and requiring caution due to potential confounding factors.

Senior author Professor Joshua Stott noted that while ADHD diagnosis rates have risen in recent years, they continue to lag behind actual prevalence, particularly among older age groups facing higher mortality risk.

An analysis of three studies within the JAMA Network Open review found that individuals taking ADHD medication had a 25% lower risk of all-cause mortality compared to untreated individuals.

Unintentional injury deaths among individuals with ADHD, such as road traffic accidents, are linked to differences in attention, risk-taking behaviors, and impulsivity.

CDC estimates show that 15 million U.S. adults (6%) and 7 million U.S. children (11.7%) have ADHD, with Mount Sinai's Dr. Jeffrey Newcorn noting that up to half of adult diagnoses occur in adulthood.

The UK Medicines and Healthcare products Regulatory Agency announced updated safety warnings for all 28 authorised antidepressants, introducing boxed warnings on suicidal thoughts and behaviours in patient information leaflets

The Commission on Human Medicines review into antidepressant safety was initiated after patients and families raised concerns regarding the communication of suicidal thoughts and persistent sexual dysfunction risks

The Medicines and Healthcare products Regulatory Agency advised healthcare professionals to discuss suicidal risks when starting antidepressants, changing dosages, or conducting routine reviews

Medicines and Healthcare products Regulatory Agency chief safety officer Dr. Alison Cave urged patients not to stop taking antidepressants without first consulting their healthcare professional

The UK Medicines and Healthcare products Regulatory Agency expects all future licensed antidepressants to incorporate updated safety warnings on suicidal thoughts and sexual dysfunction to ensure consistent communication across healthcare settings

The Medicines and Healthcare products Regulatory Agency chief safety officer Dr. Alison Cave stated that antidepressant benefits outweigh risks for the vast majority of patients under clinical supervision

In January 2025, the senior coroner for Gloucestershire issued a prevention of future deaths report following the inquest into the death of Thomas Kingston